J Korean Neurosurg Soc.  1996 Apr;25(4):846-850.

Correlation beteween Motor Disturbance and Involvement of the Internal Capsule in Hypertensive Intracerebral Hemorrhage

Affiliations
  • 1Department of Neurosurgery, Catholic University Medical College, Seoul, Korea.

Abstract

The treatment of patients with hypertensive intracerebral hemorrhage (ICH) is still controversial. Fifty-two cases with hypertensive thalamic or putaminal hemorrhage were classified into three groups on the basis of the location of the hematoma in the internal capsule on eht CT image. All the cases were confined to the anterior(Type A, 17 cases)., posterior(Type P, 25 cases) and mixed portion(Type M, 10 cases) of the posterior limb of the internal capsule, and were assigned to receive medical treatment, extraventricular drainage(EVD), or stereotactic aspiration using urokinase. This study was designed to assess the correlation between hematoma extension and the severity of motor disturbance in patients treated with stereotactic aspiration. The severity of motor weakness was found not to be related to hematoma extension, but the prognosis was frequently poor in type P and type M. The outcome was better in the stereotactic aspiration group, as compared with medical and EVD groups, especially when the hematoma was located at the posterior portion of the posterior limb of the internal capsule(p<0.05). The study suggests that stereotactic aspiration may improve the outcome of hypertensive ICH with severe motor weakness, even if the hematoma is small.

Keyword

Hypertensive intracerebral hemorrhage; Internal capsule; Stereotactic aspiration

MeSH Terms

Extremities
Hematoma
Humans
Internal Capsule*
Intracranial Hemorrhage, Hypertensive*
Prognosis
Putaminal Hemorrhage
Urokinase-Type Plasminogen Activator
Urokinase-Type Plasminogen Activator
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr